Clinical trials: Treatment Interruption
HIV, HIV - Human Immunodeficiency Virus
Bwelela Easy Study
Treatment interruption in HIV care is one of the most enduring challenges to HIV programs globally and is associated with high rates of detectable virus in the blood and overall morbidity and mortality.
- Conditions
- HIV, HIV - Human Immunodeficiency Virus, Treatment Interruption, Reengagement
- Trial name
- NCT07900750
- Testing
- Standard of Care - Routine Phone Outreach / Standard of Care - Routine Care and Counseling (SOC-RPO/SOC-RCC), Standard of Care - Routine Phone Outreach / Navigation (SOC-RPO/NAV), Standard of Care - Routine Phone Outreach / Navigation plus Community-Based Medication Delivery (SOC-RPO/NAV+CB-Med)
- Where
- Zambia
- Volunteers
- 1,500 people
- Sponsor
- Washington University School of Medicine
Acute HIV Infection, Antiretroviral Treatment Interruption
Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection
This is a Phase 2, two-step, open-label study of the outcome of analytic treatment interruption (ATI) on patients who started antiretroviral therapy (ART) during Fiebig Stage I of acute HIV infection (AHI), defined as detectable…
- Trial name
- NCT02614950
- Testing
- Treatment interruption
- Where
- Thailand
- Volunteers
- 8 people
- Sponsor
- SEARCH Research Foundation